Disposable Syringes Market Growth & Trends
The global disposable syringes market size is expected to reach a value of USD 9.9 billion by 2024, according to a new report by Grand View Research, Inc. The market growth can be attributed to the rising initiatives by the government and various NGOs to raise awareness about safe drug delivery to patients in order to avoid transmission of infections and avoid needle stick injuries to healthcare workers, especially in low-income countries.
Organizations such as WHO and UNAIDS are constantly working for this cause. Some of their programs include needle and syringe program and targeted information for drug abusers. The results of these initiatives are evident. For instance, in China, the incidence of HIV/AIDS amongst people who are drug abusers dropped from 2.5 to 0.6 cases per 100 person-years.
Major disposable syringe manufacturers are introducing new products, which is also further augmenting market growth. In January 2016, Novo Nordisk launched Tresiba, long-acting insulin degludec injection to treat diabetes. It was initially launched in the U.S. and will further target the rest of the market.
Some of the key industry players are Braun Medical, Inc.; Fresenius Kabi AG; Baxter International, Inc.; Terumo Corporation; Novo Nordisk; Covidien; Retractable Technologies, Inc.; and Becton, Dickinson, and Company.
Request a free sample copy or view report summary:
Disposable Syringes Market Report
Disposable Syringes Market Report Highlights
- Safety syringes dominated the product segment in 2015 as they provide a long-term cost advantage in comparison to the traditional syringes and thus are preferred by healthcare professionals.
- Therapeutic injections dominated the application segment in 2015 due to the extensive use of injectable drugs in the treatment of high prevalence diseases such as HIV, Hepatitis B & C, and diabetes coupled with the increasing rate of volunteer blood donations are few reasons for the high demand of infusion devices across the globe.
- Africa does not have established production systems, thus is considered a high potential market.
- In 2015, North America dominated due to the approval of injectable drugs. For instance, in July 2015, the U.S. FDA approved Praluent (alirocumab), which is the first injectable from PCSK9) inhibitors class.
- The disposable syringes market has witnessed a few major acquisitions. In 2015, Covidien was acquired by Medtronic, Inc in USD 42.9 billion. Moreover, new product development is also on a rise in the industry.
Disposable Syringes Market Segmentation
Grand View Research has segmented the global disposable syringes market by type, application, and region:
Disposable Syringes Type Outlook (Market revenue in USD Million, 2013–2024)
- Conventional syringes
- Safety syringes
- Retractable safety syringes
- Non-retractable safety syringes
Disposable Syringes Application Outlook (Market revenue in USD Million, 2013–2024)
- Immunization injections
- Therapeutic injections
Disposable Syringes Outlook (Market Revenue in USD Million, 2013–2024)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- South Africa
